Zurich, Switzerland –July 24, 2025, – Adexilis, a European pharmaceutical company that is providing access to innovative medicines in more than 20 Markets across the CEE Region, has announced a transformative distribution agreement with Bausch + Lomb, a leading global eye health company dedicated to helping people see better to live better. The agreement provides Adexilis distribution rights for Bausch + Lomb’s pharmaceutical portfolio and select consumer products within Bulgaria, Croatia, Romania, Serbia and Slovenia.
“This partnership is a transformative event for our company,” commented Adexilis CEO, Robert Karl. We are honoured that Bausch + Lomb has chosen Adexilis as distributor of its pharmaceutical portfolio and select consumer eye health products in five eastern European countries.
We should highlight, Karl continued, “that our partnership with Bausch + Lomb is a notable milestone for Adexilis. After establishing our existing partnerships within gastroenterology, woman’s health, IVF, and haemato-oncology, we are now entering ophthalmology market, which in our view is underserved, with many unmet needs existing for the millions of patients living with debilitating diseases that affect vision. With this partnership we are continuing our expansion in the region with many new jobs created and further building capabilities in specialty care, direct-to-consumer promotion and digital.”
About ADEXILIS
ADEXILIS, based out of Sarnen, Switzerland, is emerging pharma partner to companies across Europe in several therapeutic areas. Today, ADEXILIS has its own presence in Hungary, Czech Republic, Slovakia, Romania, Poland, Croatia, Slovenia, Bulgaria, Turkey and Switzerland. We will expand further across European markets and by that establish ourselves as leading company that is providing premium regional representation to our current and future partners. Next to our own affiliates, we work with trusted partners across Europe to increase our geographical reach.
Contacts Robert Karl, CEO, e-mail Robert.Karl@adexilis.com